[Infertility treatment in Klinefelter syndrome]

I Plotton; A Brosse; Groupe Fertipreserve; H Lejeune

doi:10.1016/j.gyobfe.2011.07.002

[Infertility treatment in Klinefelter syndrome]

Gynecol Obstet Fertil. 2011 Sep;39(9):529-32. doi: 10.1016/j.gyobfe.2011.07.002. Epub 2011 Aug 10.

[Article in French]

Authors

I Plotton¹, A Brosse; Groupe Fertipreserve; H Lejeune

Collaborators

Groupe Fertipreserve:
Medhi Benchaib, Aude Brac de la Perrière, Aurelie Brosse, Pierre Chatelain, Beatrice Cuzin, Andrè De Souza, Claire Lise Gay, Sandrine Giscard d'Estaing, Daniela Gorduza, Jean François Guérin, Hervé Lejeune, Jacqueline Lornage, Yves Morel, Pierre Mouriquand, Marc Nicolino, Ingrid Plotton, Michel Pugeat, Jean Yves Tamet

Affiliation

¹ Service de médecine de la reproduction, hôpital Femme-Mère-Enfant, CHU de Lyon, 59 boulevard Pinel, Bron, France.

PMID: 21835671
DOI: 10.1016/j.gyobfe.2011.07.002

Abstract

Until few years ago, Klinefelter syndrome with a homogenous 47.XXY caryotype was considered a model of absolute male sterility. In this review, we will discuss the fertility issue following TEsticular Sperm Extraction-IntraCytoplasmic Sperm Injection (TESE-ICSI) and the potential advantage of searching for and cryopreserving spermatozoa in adolescent instead of adult patients.

Publication types

English Abstract
Review

MeSH terms

Adolescent
Adult
Age Factors
Cryopreservation
Humans
Infertility, Male / etiology
Infertility, Male / genetics*
Infertility, Male / therapy*
Klinefelter Syndrome / complications*
Male
Semen Preservation / methods
Sperm Injections, Intracytoplasmic*
Treatment Outcome